Month: June 2021

Release – Ocugen Inc. Announces Ken Inchausti as Head Investor Relations and Communications

Posted on by Admin


Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications

 

MALVERN, Pa., June 21, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that Ken Inchausti has joined the company as Head, Investor Relations & Communications. Mr. Inchausti will oversee the company’s investor relations activities, corporate communications and strategic positioning, leading issues management strategy and proactive media and social media relations programming.

A senior executive with over 25 years of strategic healthcare communications experience, Mr. Inchausti joins Ocugen from Novo Nordisk Inc., where he was Senior Director, Reputation & Brand, leading corporate media relations, executive visibility, reputation strategy and research, crisis and issues management and corporate communications for the US affiliate.

“Ken is joining us at a critical time where we are continuing our plans for obtaining regulatory approval for and potentially commercializing COVAXIN® in the US and Canada, as well as the planned initiation our Phase 1/2a clinical trial for OCU400. His talents and expertise will be key as we seek to find new ways of raising our profile with multiple stakeholders as a leader committed to global public health and fighting this pandemic, and also driving innovation through our gene therapy platform to find cures for leading causes of blindness,” said Sanjay Subramanian, MBA, Chief Financial Officer and Head of Corporate Development at Ocugen, Inc.

Mr. Inchausti has worked across multiple sectors within healthcare – from pharmaceuticals to hospitals and providers to patient advocacy. Prior to Novo Nordisk, he held communications positions at GSK, Premier, Inc., Fleishman Hillard, and the American Diabetes Association.

Mr. Inchausti holds a bachelor’s degree in Communications from Old Dominion University.

About Ocugen, Inc.
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug — “one to many,” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. We are co-developing Bharat Biotech’s COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets. For more information, please visit www.ocugen.com.

Cautionary Note on Forward-Looking Statements 
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. Such forward-looking statements within this press release include, without limitation, the intended use of net proceeds from the registered direct offering. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from our current expectations, such as market and other conditions. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (the “SEC”), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events or otherwise, after the date of this press release.

Ocugen Contact:
Ocugen, Inc.
Ken Inchausti
Head, Investor Relations and Communications
ken.inchausti@ocugen.com

Please submit investor-related inquiries to: IR@ocugen.com

Media Contact:
LaVoieHealthScience
Lisa DeScenza
ldescenza@lavoiehealthscience.com
+1 978-395-5970

Comstock Mining Announces Participation in Noble Capital Markets Virtual Road Show Series

Posted on by Admin


Comstock Mining Announces Participation in Noble Capital Markets Virtual Road Show Series

 

Virginia City, NV (June 21, 2021) Comstock Mining Inc. (the “Company”) (NYSE American: LODE) announced today its participation in Noble Capital Markets’ Virtual Road Show Series, presented by Channelchek, scheduled for this Tuesday, June 22, 2021, at 10 AM PDT / 1 PM EDT.

The virtual road show will feature a corporate presentation from Comstock Mining’s Executive Chairman and CEO, Corrado De Gasperis, followed by a Q & A session facilitated by Noble Senior Research Analyst Mark Reichman, including questions submitted by the audience.

There is no charge for this live broadcast of the virtual road show that is open to all investors at any level.

Presentation details: 

Date: Tuesday, June 22, 2021

Time: 10:00-11:00am PDT

Investors can register for the conference: Registration (gotowebinar.com)

  

About Comstock Mining Inc.

Comstock (NYSE: LODE) is an emerging leader in the sustainable extraction, valorization, and production of innovation-based, clean, renewable natural resources, with a focus on high-value, cash-generating, strategic materials that are essential to meeting the rapidly increasing global demand for clean energy, carbon-neutrality, and natural products. To learn more, please visit www.comstockmining.com.

Comstock is also set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4, 2021. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

About Noble Capital Markets

Noble Capital Markets, Inc. was incorporated in 1984 as a full-service SEC / FINRA registered broker-dealer, dedicated exclusively to serving underfollowed small / microcap companies through investment banking, wealth management, trading & execution, and equity research activities. Over the past 36 years, Noble has raised billions of dollars for these companies and published more than 45,000 equity research reports. www.noblecapitalmarkets.com email: contact@noblecapitalmarkets.com

About Channelchek

Channelchek (.com) is a comprehensive investor-centric portal – featuring more than 6,000 emerging growth companies – that provides advanced market data, independent research, balanced news, video webcasts, exclusive c-suite interviews, and access to virtual road shows. The site is available to the public at every level without cost or obligation. Research on Channelchek is provided by Noble Capital Markets, Inc., an SEC / FINRA registered broker-dealer since 1984. channelchek.vercel.app email: contact@channelchek.vercel.app

Forward-Looking Statements

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: consummation of all pending transactions; project, asset or Company valuations; future industry market conditions; future explorations, acquisitions, investments and asset sales; future performance of and closings under various agreements; future changes in our exploration activities; future estimated mineral resources; future prices and sales of, and demand for, our products; future impacts of land entitlements and uses; future permitting activities and needs therefor; future production capacity and operations; future operating and overhead costs; future capital expenditures and their impact on us; future impacts of operational and management changes (including changes in the board of directors); future changes in business strategies, planning and tactics and impacts of recent or future changes; future employment and contributions of personnel, including consultants; future land sales, investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives; the nature and timing of and accounting for restructuring charges and derivative liabilities and the impact thereof; contingencies; future environmental compliance and changes in the regulatory environment; future offerings of equity or debt securities; asset sales and associated costs; future working capital, costs, revenues, business opportunities, debt levels, cash flows, margins, earnings and growth. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in our filings with the SEC and the following: counterparty risks; capital markets’ valuation and pricing risks; adverse effects of climate changes or natural disasters; global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration or mining activities; contests over title to properties; potential dilution to our stockholders from our stock issuances and recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting businesses; permitting constraints or delays; decisions regarding business opportunities that may be presented to, or pursued by, us or others; the impact of, or the non-performance by parties under agreements relating to, acquisitions, joint ventures, strategic alliances, business combinations, asset sales, leases, options and investments to which we may be party; changes in the United States or other monetary or fiscal policies or regulations; interruptions in production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, zinc, cyanide, water, diesel fuel and electricity); changes in generally accepted accounting principles; adverse effects of terrorism and geopolitical events; potential inability to implement business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors or others; assertion of claims, lawsuits and proceedings; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the SEC; potential inability to list our securities on any securities exchange or market; inability to maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related calls or discussions constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

 

Contact information:
Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
ComstockMining.com		 Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com		 Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com

Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications

Posted on by Admin


Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications

 

MALVERN, Pa., June 21, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that Ken Inchausti has joined the company as Head, Investor Relations & Communications. Mr. Inchausti will oversee the company’s investor relations activities, corporate communications and strategic positioning, leading issues management strategy and proactive media and social media relations programming.

A senior executive with over 25 years of strategic healthcare communications experience, Mr. Inchausti joins Ocugen from Novo Nordisk Inc., where he was Senior Director, Reputation & Brand, leading corporate media relations, executive visibility, reputation strategy and research, crisis and issues management and corporate communications for the US affiliate.

“Ken is joining us at a critical time where we are continuing our plans for obtaining regulatory approval for and potentially commercializing COVAXIN® in the US and Canada, as well as the planned initiation our Phase 1/2a clinical trial for OCU400. His talents and expertise will be key as we seek to find new ways of raising our profile with multiple stakeholders as a leader committed to global public health and fighting this pandemic, and also driving innovation through our gene therapy platform to find cures for leading causes of blindness,” said Sanjay Subramanian, MBA, Chief Financial Officer and Head of Corporate Development at Ocugen, Inc.

Mr. Inchausti has worked across multiple sectors within healthcare – from pharmaceuticals to hospitals and providers to patient advocacy. Prior to Novo Nordisk, he held communications positions at GSK, Premier, Inc., Fleishman Hillard, and the American Diabetes Association.

Mr. Inchausti holds a bachelor’s degree in Communications from Old Dominion University.

About Ocugen, Inc.
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug — “one to many,” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. We are co-developing Bharat Biotech’s COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets. For more information, please visit www.ocugen.com.

Cautionary Note on Forward-Looking Statements 
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. Such forward-looking statements within this press release include, without limitation, the intended use of net proceeds from the registered direct offering. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from our current expectations, such as market and other conditions. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (the “SEC”), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events or otherwise, after the date of this press release.

Ocugen Contact:
Ocugen, Inc.
Ken Inchausti
Head, Investor Relations and Communications
ken.inchausti@ocugen.com

Please submit investor-related inquiries to: IR@ocugen.com

Media Contact:
LaVoieHealthScience
Lisa DeScenza
ldescenza@lavoiehealthscience.com
+1 978-395-5970

Release – Great Bear Provides Assays Across Width of LP Fault Zone

Posted on by Admin


Great Bear Provides Two New Detailed High-Grade Long Sections and Reaches 318 Drill Holes Reported on Two Year Anniversary of LP Fault Discovery

 

June 21, 2021 – Vancouver, British Columbia, Canada – Great Bear Resources Ltd. (the “Company” or “Great Bear”, TSX-V: GBR; OTCQX: GTBAF) today reported results from its ongoing fully funded $45 million 2021 exploration program at its 100% owned flagship Dixie Project in the Red Lake district of Ontario.

Chris Taylor, President and CEO of Great Bear said, “We are now only months away from completing more than fifty 40 – 50 metre spaced drill sections along 4.2 kilometres of the LP Fault zone.  These will be required for maiden mineral resource estimation modelling of the near-surface (0 – 400 metre depth), central area of the zone.  In this release we provide example cross section 20625, which intersects both high-grade and bulk tonnage gold over an approximate width of 200 metres, as shown on Figure 1.  We also provide a table of all individual sample assay results to our web site from every drill hole traversing the upper 200 metres from surface on this section.  Additional representative sections will be provided as drilling progresses.”

Example Cross Section 20625

New drill hole BR-315 was completed within a 100 metre previously undrilled gap in section 20625 and successfully intersected the three high-grade domains BR7, AURO20 and BR1 which were described in news releases on May 19 and June 3, 2021.  It also intersected a fourth recently defined high-grade gold domain, BR4, southwest of the other high-grade domains.  BR-315 also intersected bulk tonnage style gold mineralization between the high-grade domains.  Highlights of results include:

  • High-grade intercepts include 400.00 g/t gold over 0.50 metres from 175.50 to 176.00 metres downhole.  The interval is within newly defined high-grade domain BR4.
  • Bulk-tonnage gold intercepts include 2.23 g/t gold over 77.40 metres from 69.60 to 147.00 metres downhole.
  • This included 5.14 g/t gold over 20.70 metres from 75.30 to 96.00 metres downhole as the drill hole traversed high-grade domain AURO20, and 3.83 g/t over 12.15 metres from 117.50 to 129.65 metres downhole as the drill hole traversed domain BR7.
  • BR-315 was collared within high-grade domain BR1, as shown on Figure 1.  It intersected 7.58 g/t gold over 1.95 metres from 56.90 to 58.85 metres downhole corresponding to the up-dip projection of domain BR1 on this drill section.

On the same section, new drill hole BR-314 was collared near the southwest edge of the LP Fault zone.  The hole successfully extended high-grade domain BR7 to the near-surface.  Results include:

  • 55.40 g/t gold over 0.70 metres from 48.70 – 49.40 metres downhole, within a broader interval of 5.39 g/t gold over 10.40 metres from 43.35 to 53.75 metres downhole.

Figure 
1: Example cross section 20625 showing all individual assays from reported highlighted intervals with labelled high-grade domains in the near-surface, 200 m x 200 m area of the LP Fault zone. Gold image is of a select interval and does not represent all gold mineralization on the property.

A new table of all individual sample assays within the main gold-hosting felsic volcanic rocks in drill holes BR-140, 141, 212, 299, 314 and 315 are provided on the Company’s web site at https://greatbearresources.ca/projects/overview/dixie-project-data/.   These holes collectively define the mineralized zone over a width of approximately 200 metres, and from surface to approximately 200 metres vertical depth at this location.

 

Bulk Tonnage Gold Drilling

11 of the 13 drill holes in this release tested the bulk-tonnage style “halo” adjacent to the high-grade domains along more than 2.5 kilometres of strike length.  Drilling intersected gold mineralization from bedrock surface to 500 metres vertical depth.

Results from the bulk tonnage style gold mineralization are presented separately from the high-grade domains, and include:

  • Drill hole BR-309 intersected 80.90 metres of bulk-tonnage style gold mineralization over 117 metres of core length between approximately 85 metres and 180 metres vertical depth.  Intervals include:

    • 0.85 g/t gold over 23.00 metres from 91.10 to 114.10 metres downhole.
    • 0.50 g/t gold over 31.00 metres from 142.00 to 173.00 metres downhole.
    • 0.57 g/t gold over 26.90 metres from 193.00 to 219.90 metres downhole.
  • Drill hole BR-332 intersected 1.02 g/t gold over 52.65 metres from 176.25 to 228.90 metres downhole.  The interval extends from approximately 150 to 200 metres vertical depth.
  • Drill hole BR-306 intersected 1.08 g/t gold over 106.70 metres from 397.30 to 504.00 metres downhole.  The interval extends from approximately 340 to 430 metres vertical depth. 
  • Drill hole BR-304 intersected 0.73 g/t gold over 74.35 metres from 495.15 to 569.50 metres downhole in drill hole BR-304. This interval extends from approximately 430 to 500 metres vertical depth.

Results demonstrate the gold mineralized zone remains open to extension in all tested locations.  The deepest drilling to date has been to approximately 800 metres vertical depth (March 29, 2021).

New Drill Plans

The Company has now released results from 331 LP Fault drill holes.  An additional 50 drill holes are in various stages of completion, ranging from active drilling to being complete and awaiting receipt of assays.  Approximately 400 drill holes are believed to be required for near-surface maiden mineral resource estimation, and this work is anticipated to be completed over the coming months.

For the first time in a year, follow up drilling of previously successful reconnaissance holes completed elsewhere along 11 kilometres of the LP Fault will now be undertaken, in addition to the systematic extension and infill drilling of the central LP Fault zone which will remain ongoing.  Figure 3.

Regional drilling will include a one kilometre step-out to the east of the central 4.2 kilometre drill grid.  Concurrently, deeper drilling of the central LP Fault zone below the approximately 400 metre vertical depth of the planned resource area will continue into 2022.  Drilling will also recommence during summer/fall 2021 on the Hinge and Dixie Limb zones.

Table 
1: Current LP Fault drill results targeting the bulk-tonnage style halo of the gold mineralized system, arranged from southeast (top) to northwest (bottom) .  Only drill holes BR-314 and BR-315 targeted the high-grade core of the zone.

Drill Hole

 

From (m)

To (m)

Width* (m)

Gold (g/t)

Section

BR-289

 

326.40

327.00

0.60

6.50

19675

BR-340

 

168.55

176.15

7.60

1.02

19675

 

and

290.10

290.60

0.50

8.09

 

BR-326

 

15.50

16.50

1.00

2.13

19825

BR-322

 

225.20

274.00

48.80

0.27

20200

 

and

277.50

303.00

25.50

0.35

 

BR-324

 

124.00

138.00

14.00

0.56

20275

BR-312

 

280.80

304.70

23.90

0.51

20500

 

including

287.60

291.75

4.15

1.31

 

BR-314

 

43.35

53.75

10.40

5.39

20625

 

including

46.10

51.65

5.55

9.57

 

 

and including

48.70

49.40

0.70

55.40

 

BR-315

 

56.90

58.85

1.95

7.58

20625

 

and

69.60

147.00

77.40

2.23

 

 

including

75.30

96.00

20.70

5.14

 

 

and including

117.50

129.65

12.15

3.83

 

 

and

152.40

185.00

32.60

6.68

 

 

including

175.50

176.00

0.50

400.00

 

BR-319

Intersected anomalous gold values to southwest of LP Fault zone

20825

BR-332

 

176.25

228.90

52.65

1.02

21975

 

including

212.50

222.05

9.55

3.56

 

 

and including

215.85

222.05

6.20

4.87

 

 

and including

217.55

219.05

1.50

12.70

 

BR-306

 

397.30

504.00

106.70

1.08

22125

 

including

408.60

428.75

20.15

2.58

 

 

and including

420.80

425.40

4.60

4.80

 

 

and including

423.15

425.40

2.25

6.22

 

BR-304

 

477.00

478.00

1.00

5.06

22150

 

and

495.15

569.50

74.35

0.73

 

 

including

525.00

538.55

13.55

1.00

 

 

and

564.05

564.50

0.45

5.70

 

BR-309

 

91.10

114.10

23.00

0.85

22225

 

including

91.80

102.00

10.20

1.34

 

 

and including

91.80

93.00

1.20

4.37

 

 

  

142.00

173.00

31.00

0.50

 

 

including

165.60

167.90

2.30

2.71

 

 

and

193.00

219.90

26.90

0.57

 

 

including

201.00

208.40

7.40

1.06

 

* Widths are drill indicated core length, as insufficient drilling has been undertaken to determine true widths at this time.  Average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher grade gold intercepts.  Interval widths are calculated using a 0.10 g/t gold cut-off grade with up to 3 m of internal dilution of zero grade.

Figure 
2: Complete drill section 20625 spanning an 800 m x 800 m area with highlighted assays. 

Figure 3: Map of current drill results and current and upcoming drill areas at the Dixie project.

Great Bear’s progress can be followed using the Company’s plan maps, long sections and cross sections, and through the VRIFY model posted at the Company’s web site at www.greatbearresources.ca.  All LP Fault drill hole highlighted assays, plus drill collar locations and orientations can also be downloaded at the Company’s web site.

Drill collar location, azimuth and dip for drill holes included in this release are provided in the table below (UTM zone 15N, NAD 83):

Hole ID

Easting

Northing

Elevation

Length

Dip

Azimuth

BR-289

457918

5634054

364

517

-54

201

BR-304

455888

5635271

375

672

-58

226

BR-306

455865

5635237

375

510

-59

223

BR-309

455665

5635122

376

321

-61

229

BR-312

457007

5634044

356

348

-56

210

BR-314

456904

5634082

356

339

-55

212

BR-315

456944

5634181

356

327

-57

212

BR-319

456704

5634153

360

282

-50

210

BR-322

457418

5634182

358

657

-59

204

BR-324

457334

5634164

355

561

-50

207

BR-326

457660

5633822

361

257

-50

206

BR-332

455845

5634942

373

356

-61

224

BR-340

457878

5633929

364

408

-55

212

About the Dixie Project

About the Dixie Project

The Dixie Project is 100% owned, comprised of 9,140 hectares of contiguous claims that extend over 22 kilometres, and is located approximately 25 kilometres southeast of the town of Red Lake, Ontario. The project is accessible year-round via a 15 minute drive on a paved highway which runs the length of the northern claim boundary and a network of well-maintained logging roads.

The Dixie Project hosts two principal styles of gold mineralization:

  • High-grade gold in quartz veins and silica-sulphide replacement zones (Dixie Limb, Hinge and Arrow zones). Hosted by mafic volcanic rocks and localized near regional-scale D2 fold axes.  These mineralization styles are also typical of the significant mined deposits of the Red Lake district.
  • High-grade disseminated gold with broad moderate to lower grade envelopes (LP Fault).  The LP Fault is a significant gold-hosting structure which has been seismically imaged to extend to 14 kilometres depth (Zeng and Calvert, 2006), and has been interpreted by Great Bear to have up to 18 kilometres of strike length on the Dixie property.  High-grade gold mineralization is controlled by structural and geological contacts, and moderate to lower-grade disseminated gold surrounds and flanks the high-grade intervals.  The dominant gold-hosting stratigraphy consists of felsic sediments and volcanic units.

About Great Bear

Great Bear Resources Ltd. is a well-financed gold exploration company managed by a team with a track record of success in mineral exploration.  Great Bear is focused in the prolific Red Lake gold district in northwest Ontario, where the company controls over 200 km2 of highly prospective tenure across 4 projects, all 100% owned: The flagship Dixie Project, the Pakwash Property, the Sobel Property, and the Red Lake North Property, all of which are accessible year-round through existing roads.

QA/QC and Core Sampling Protocols

Drill core is logged and sampled in a secure core storage facility located in Red Lake Ontario.  Core samples from the program are cut in half, using a diamond cutting saw, and are sent to Activation Laboratories in Ontario, an accredited mineral analysis laboratory, for analysis. All samples are analysed for gold using standard Fire Assay-AA techniques. Samples returning over 10.0 g/t gold are analysed utilizing standard Fire Assay-Gravimetric methods.  Pulps from approximately 5% of the gold mineralized samples are submitted for check analysis to a second lab.  Selected samples are also chosen for duplicate assay from the coarse reject of the original sample.  Selected samples with visible gold are also analyzed with a standard 1 kg metallic screen fire assay.  Certified gold reference standards, blanks and field duplicates are routinely inserted into the sample stream, as part of Great Bear’s quality control/quality assurance program (QAQC).  No QAQC issues were noted with the results reported herein. 

Qualified Person and NI 43-101 Disclosure

Mr. R. Bob Singh, P.Geo, VP Exploration, and Ms. Andrea Diakow P.Geo, VP, Projects for Great Bear are the Qualified Persons as defined by National Instrument 43-101 responsible for the accuracy of technical information contained in this news release.

 

ON BEHALF OF THE BOARD

“Chris Taylor”                                 

Chris Taylor, President and CEO

 

Investor Inquiries:

Mr. Knox Henderson

Tel: 604-646-8354

Direct: 604-551-2360

info@greatbearresources.ca

www.greatbearresources.ca

 

Cautionary note regarding forward-looking statements

This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian and U.S. securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. The forward-looking information contained herein is provided for the purpose of assisting readers in understanding management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes.

Forward-looking information are based on management of the parties’ reasonable assumptions, estimates, expectations, analyses and opinions, which are based on such management’s experience and perception of trends, current conditions and expected developments, and other factors that management believes are relevant and reasonable in the circumstances, but which may prove to be incorrect.

Such factors, among other things, include: impacts arising from the global disruption caused by the Covid-19 coronavirus outbreak, business integration risks; fluctuations in general macroeconomic conditions; fluctuations in securities markets; fluctuations in spot and forward prices of gold or certain other commodities; change in national and local government, legislation, taxation, controls, regulations and political or economic developments; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected formations pressures, cave-ins and flooding); discrepancies between actual and estimated metallurgical recoveries; inability to obtain adequate insurance to cover risks and hazards; the presence of laws and regulations that may impose restrictions on mining; employee relations; relationships with and claims by local communities and indigenous populations; availability of increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development (including the risks of obtaining necessary licenses, permits and approvals from government authorities); and title to properties.

Great Bear undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents management’s best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.




Release – Comstock Mining Announces Participation in Virtual Road Show Series

Posted on by Admin


Comstock Mining Announces Participation in Noble Capital Markets Virtual Road Show Series

 

Virginia City, NV (June 21, 2021) Comstock Mining Inc. (the “Company”) (NYSE American: LODE) announced today its participation in Noble Capital Markets’ Virtual Road Show Series, presented by Channelchek, scheduled for this Tuesday, June 22, 2021, at 10 AM PDT / 1 PM EDT.

The virtual road show will feature a corporate presentation from Comstock Mining’s Executive Chairman and CEO, Corrado De Gasperis, followed by a Q & A session facilitated by Noble Senior Research Analyst Mark Reichman, including questions submitted by the audience.

There is no charge for this live broadcast of the virtual road show that is open to all investors at any level.

Presentation details: 

Date: Tuesday, June 22, 2021

Time: 10:00-11:00am PDT

Investors can register for the conference: Registration (gotowebinar.com)

  

About Comstock Mining Inc.

Comstock (NYSE: LODE) is an emerging leader in the sustainable extraction, valorization, and production of innovation-based, clean, renewable natural resources, with a focus on high-value, cash-generating, strategic materials that are essential to meeting the rapidly increasing global demand for clean energy, carbon-neutrality, and natural products. To learn more, please visit www.comstockmining.com.

Comstock is also set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4, 2021. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

About Noble Capital Markets

Noble Capital Markets, Inc. was incorporated in 1984 as a full-service SEC / FINRA registered broker-dealer, dedicated exclusively to serving underfollowed small / microcap companies through investment banking, wealth management, trading & execution, and equity research activities. Over the past 36 years, Noble has raised billions of dollars for these companies and published more than 45,000 equity research reports. www.noblecapitalmarkets.com email: contact@noblecapitalmarkets.com

About Channelchek

Channelchek (.com) is a comprehensive investor-centric portal – featuring more than 6,000 emerging growth companies – that provides advanced market data, independent research, balanced news, video webcasts, exclusive c-suite interviews, and access to virtual road shows. The site is available to the public at every level without cost or obligation. Research on Channelchek is provided by Noble Capital Markets, Inc., an SEC / FINRA registered broker-dealer since 1984. www.channelchek.com email: contact@channelchek.com

Forward-Looking Statements

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: consummation of all pending transactions; project, asset or Company valuations; future industry market conditions; future explorations, acquisitions, investments and asset sales; future performance of and closings under various agreements; future changes in our exploration activities; future estimated mineral resources; future prices and sales of, and demand for, our products; future impacts of land entitlements and uses; future permitting activities and needs therefor; future production capacity and operations; future operating and overhead costs; future capital expenditures and their impact on us; future impacts of operational and management changes (including changes in the board of directors); future changes in business strategies, planning and tactics and impacts of recent or future changes; future employment and contributions of personnel, including consultants; future land sales, investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives; the nature and timing of and accounting for restructuring charges and derivative liabilities and the impact thereof; contingencies; future environmental compliance and changes in the regulatory environment; future offerings of equity or debt securities; asset sales and associated costs; future working capital, costs, revenues, business opportunities, debt levels, cash flows, margins, earnings and growth. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in our filings with the SEC and the following: counterparty risks; capital markets’ valuation and pricing risks; adverse effects of climate changes or natural disasters; global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration or mining activities; contests over title to properties; potential dilution to our stockholders from our stock issuances and recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting businesses; permitting constraints or delays; decisions regarding business opportunities that may be presented to, or pursued by, us or others; the impact of, or the non-performance by parties under agreements relating to, acquisitions, joint ventures, strategic alliances, business combinations, asset sales, leases, options and investments to which we may be party; changes in the United States or other monetary or fiscal policies or regulations; interruptions in production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, zinc, cyanide, water, diesel fuel and electricity); changes in generally accepted accounting principles; adverse effects of terrorism and geopolitical events; potential inability to implement business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors or others; assertion of claims, lawsuits and proceedings; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the SEC; potential inability to list our securities on any securities exchange or market; inability to maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related calls or discussions constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

 

Contact information:
Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
ComstockMining.com		 Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com		 Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com

Golden Predator Mining (NTGSF)(GPY:CA) – Keeping an Eye on Critical Milestones

Posted on by Admin

Monday, June 21, 2021

Golden Predator Mining (NTGSF)(GPY:CA)
Keeping an Eye on Critical Milestones

Golden Predator Mining Corp is a Canada based exploration stage company engaged in the business of acquiring and exploring mineral properties. It owns properties primarily in Yukon, Canada. Some of the company’s projects located in Yukon are the 3 Aces, Sprogge, Reef, Brewery Creek, Marg, Sonora Gulch, Grew Creek, Upper Hyland and others.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Quartz mining and water licenses. Brewery Creek’s quartz mining and water licenses expire on December 31, 2021, and the company has submitted renewal applications for an additional 10 years under existing terms. The company is also working with the Yukon Environmental and Socioeconomic Assessment Board (YESAB) to determine if any assessment is needed for the license renewals. Future amendments to the licenses would be evaluated separately based on any proposals by the company to mine outside of current licensed areas.

    Bankable feasibility study (BFS).  A bankable feasibility study, expected to be completed early in the third quarter of 2021, is being completed by Kappes Cassiday & Associates and will include a multi-year mine plan for Brewery Creek. Once completed, Golden Predator will work with First Nations and Yukon government to expand the licensed mining area to expand the licensed mining area to include new …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

QuickChek – June 21, 2021

Posted on by Admin



Comstock Mining Announces Participation in Noble Capital Markets Virtual Road Show Series

Comstock Mining announced its participation in Noble Capital Markets’ Virtual Road Show Series, presented by Channelchek, scheduled for this Tuesday, June 22, 2021, at 10 AM PDT / 1 PM EDT

Research, News & Market Data on Comstock Mining

Watch recent presentation from Comstock Mining



Great Bear Provides Two New Detailed High-Grade Long Sections

Great Bear Resources announced results from its ongoing fully funded $45 million 2021 exploration program at its 100% owned flagship Dixie Project in the Red Lake district of Ontario

Research, News & Market Data on Great Bear

Watch recent presentation from Great Bear



Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications

Ocugen, Inc. announced that Ken Inchausti has joined the company as Head, Investor Relations & Communications

Research, News & Market Data on Ocugen

Watch recent presentation from NobleCon17

Stay up to date. Follow us:

The Taishan Plant May be the Dip ESG Investors Wanted

Posted on by Admin 

Image credit: Can Pac Swire (Flickr)


Is the Taishan News Story a Buying Opportunity for Investors?

 

One week after uranium mining companies saw their stocks negatively respond to a situation with a nuclear plant in Southeast China, investors are deciding if this is now a buying opportunity. A decline in some uranium mining sector stocks, after a week, is similar to one week after Fukushima’s seemingly more serious problems. Currently the Taishan Nuclear Power Plant, which is two-thirds owned by the French and one-third owned by the Chinese, is still operating, but there have been operational performance issues reported. The French have asked for help from the U.S. in assessing the complete situation.

 

About the Nuclear Trend

Nuclear energy has recently become widely embraced by the move to eliminate burning fossil fuels that emit carbon into the atmosphere. There is now a need for electricity production from a source as productive and reliable as fossil fuels to supplement the growing solar and wind output. This need is evident today, with newspaper headlines already showing how states like California are concerned that generation may not keep up with their summer demand. 

 

News from China

The West often views information coming out of The People’s Republic of China with suspicion. To date, reports are that the reactor is still running, and there has not been a radioactive leak of any kind. On its website this past Sunday the Taishan Nuclear Power Plant published a statement, maintaining that environmental readings for both the plant and its surrounding area were “normal.”

The two nuclear reactors in Taishan are both operational, the statement said, adding that Unit 2 had recently completed an “overhaul” and “successfully connected to the grid on June 10, 2021.” The statement did not define why or how the plant was overhauled.

The situation is worth investors paying close attention to. If this is indeed somewhat routine and the market has overreacted, mining stocks could quickly recover and even continue their march upward as the trend toward lower emissions and more energy demand continue.

 

About the Dip

Below is a one-year chart showing four plots. The uranium mining ETF (as a benchmark), two mining stocks that have been far exceeding, it along with one that tracks it more closely.

The amber line is the ETF ticker symbol URA. Year over year the basket of stocks making up the ETF’s performance have increased 92.44%. It had reached its 12-month high in performance earlier this month when on June 8th it had attained a 123.84% increase.  The decline from one week earlier, when news of the Taishen plant started circulating, the ETF is down 4.83%.

 

 

The light blue line is Energy Fuels (UUUU). Energy Fuels, based in Colorado, is the largest uranium producer in the U.S. and holds more production capacity and uranium resources than any other U.S. producer. Their year-over-year performance to date is an increase of 277.35%. The price change from one week earlier when CNN broke the news of the Taishen plant is down 2.2%.

The purple plot is enCore Energy (ENCUF). enCore Energy Corp. is focused on working towards becoming a domestic United States uranium producer. The company has existing resources in the southwest United States and licensed uranium production facilities in Texas. Their year-over-year has been 543.48%, it reached a peak just before the questions surrounding the Chinese plant. ENCUFs price decline over the past week has been 10%.

The orange line is Blue Sky Uranium (BKUCF). Blue Sky Uranium Corp is a junior mineral exploration company based in Canada. The company focuses on uranium exploration projects in southern Argentina. The year-over-year performance is now at 64.55%. Blue Sky had reached its one year high back in April. They are currently down 8.40% from their one-week earlier levels.

 

 

Take-Away

Investing always includes many unknowns. As it relates to uranium mining companies, what is known is the industry is experiencing triple-digit returns and trending higher. The sector has been helped by increasing support from those that are pushing the world toward lower carbon emissions, which is a global movement gaining more power.

What isn’t known is whether this is an event that is typical and will receive very little attention after this, or if there is a full-blown problem that will put in question how strongly the world embraces nuclear as the preferred road to meeting growing energy demands.

 

Suggested Reading:

How Does Uranium Fit Into the ESG Landscape?

How does the Gates Buffett Natrium Reactor Work?



Advanced Battery Storage Goals of the Department of Energy

Why Uranium Prices Have Been Rising

 

Sources:

https://www.cnn.com/2021/06/14/politics/china-nuclear-reactor-leak-us-monitoring/index.html

https://www.scmp.com/news/china/science/article/3138214/chinas-nuclear-safety-queried-over-taishan-reactor-it-wants-lead

https://www.thedailybeast.com/us-scrambles-to-investigate-leak-at-chinese-nuclear-plant

 

Stay up to date. Follow us:

           


Stay up to date. Follow us:

The GEO Group, Inc. (GEO) – CEO Zoley Buys Shares

Posted on by Admin

Monday, June 21, 2021

The GEO Group, Inc. (GEO)
CEO Zoley Buys Shares

With over 94,000 beds owned, leased or managed across its business lines and serving over 260,000 people daily, GEO is a leading provider of mission critical real estate to its governmental partners. The Company is the first fully integrated equity REIT specializing in the design, financing, development, and operation of secure facilities, processing centers, and community reentry centers in the U.S., Australia, South Africa, and the U.K.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    CEO Zoley Adds to His Already Large Holdings. On June 15th, GEO CEO George Zoley reported the open market purchase of 166,644 GEO shares at an average cost of $6.75 per share for a total investment of $1.12 million. Following the transactions, Mr. Zoley directly owned 3 million GEO common shares, held an additional 518,752 shares through restricted stock, and indirectly owned 104,850 shares held in trust. We view the recent purchases as confirmation of Mr. Zoley’s belief that GEO shares remain undervalued at the current share price.

    Meme Stock Creating Volatility.  Given its large short position, some 52% of the float as of May 28th, GEO shares have attracted the interest of the Reddit crowd. This has resulted in large price swings, with the shares briefly touching $11 on 6/9 after closing at $6.11 on 6/8 before retreating back to $6.62 on 6/15. We continue to expect more-than-normal volatility until the Reddit crowd moves onto …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Why the Smart Money is the Individual Investor in 2021

Posted on by Admin


For How Long Will the Individual Investor Have Market Control?

 

Game over, the smart money is now the self-directed investor.

Individual Investors are continuing to stymie investment markets and make even more headway in their newfound leadership role. During the first half of this year, new investment accounts opened by self-directed investors have already equaled the large amount opened through all of 2020. That is more than 10 million new individual trading accounts.

The new money and focus that is different than professional money managers has positively impacted many companies’ stocks like GameStop (GME), AMC Entertainment (AMC), and more recently, GEO Corp (GEO). The new market participants have taken control and have sent the cryptocurrency Dogecoin, which was brought to life as a goof, soaring. The self-directed traders have also formed alliances on social media to powerfully take the other side of trades of hedge funds and portfolio managers who were previously thought of as the “smart money,” and succeed in inflicting losses on them.

 

What is “Smart Money?”

If you are within a group that is more often correct than incorrect, if your sources which impact your decisions have more power than others in the market, and other market players are watching to see what you are doing to follow, then you are the “smart money.” But the road to becoming the group that is the “smart money” is a different question. The Wall Street Journal recently wrote an article on a similar subject and defined four characteristics. They are if your peers have increasing Trading Volume, quickness to spot or create Trends, they are quick to know a Trends End, they cause Changed Behavior of other market participants.

Trading Volume – In the past, individual investors’ trading activity rarely impacted price movements in the markets. Being impactful began to occur in 2019, when online brokerages moved to commission-free trading. This helped grow activity. The lockdowns that were enacted in response to the pandemic had the effect of bringing new investors online to interact with the markets. This all helped drive self-directed participants’ trading volume numbers to 20% in 2020. This is roughly double the percentage from the previous decade.

Trends

–

Individual investors have been entering some trades in unison – GameStop is the easiest example. GME surged as high as $483 on Jan. 28 to complete a four-day run of 643% .  With the help of a few social media groups, individual investors will, en masse, jump into trades and quickly drive the price – surprising others active in the stocks. They can depart just as unsuspectingly.

Trends End – Technology has shortened the lifespan of many trends. Zero-priced commissions and the ability to communicate with other individual investors has allowed for groups to begin and end trends. First-hand early knowledge has now tipped into the hands of the self-directed money that is still befuddling institutions.

Changed Behavior – Institutional short sellers of stocks like GameStop earlier in 2021 endured a good deal of pain and anxiety. The outcome is a new respect for the power of individuals to take control over market pricing mechanisms and have the size behind them to cause the other to react against their original plan.

In the GameStop example, short interest has fallen dramatically. GameStop’s short interest currently hovers around 21%, compared with more than 100% last year.  Several other popular individual investor stocks have seen short interest decline substantially.

 

Take-Away

It is never actually “game-over” in the stock market. The capitalist mindset of most investors just sees new challenges to determine how they could profit. Long considered not-so-smart money by Wall Street, the impact of individual investors has captured the attention of everyone ranging from hedge-fund managers to regulators to executives of companies they are trading. The reason, of course, there is “size” behind them.

Individual investors have poured a net $140.57 billion into the U.S. stock market this year. That is up roughly 33% from the same period a year ago and more than six times the amount during the same stretch in 2019.

 

Paul Hoffman

Managing Editor, Channelchek

 

Suggested Reading:

The Sustainability of Growing Margin Debt

Do Robinhood Investors Make Money?



Will Robinhood be Sued for Gamification?

How Good are Experts at Predicting the Market?

 

Sources:

https://www.wsj.com/articles/it-isnt-just-amc-retail-traders-increase-pull-on-the-stock-market-11624008602?mod=hp_lead_pos4

 

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Release – FAT Brands Inc. Announces Pricing of Public Offering of Series B Cumulative Preferred Stock

Posted on by Admin

 


FAT Brands Inc. Announces Pricing of Public Offering of Series B Cumulative Preferred Stock

 

Beverly Hills, CA, June 17, 2021 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT, FATBP, FATBW), a leading global franchising company and parent company of iconic brands including Fatburger, Johnny Rockets, and seven other restaurant concepts, today announced the pricing of an underwritten public offering of 400,000 shares of 8.25% Series B Cumulative Preferred Stock at a price to the public of $20.00 per share.

The gross proceeds to the Company are expected to be $8,000,000 prior to deducting underwriting discounts and estimated offering expenses. The Company has also granted to the underwriters a 45-day option to acquire an additional 60,000 shares of 8.25% Series B Cumulative Preferred Stock to cover over-allotments, if any.

The offering is expected to close on June 22, 2021, subject to customary closing conditions.

FAT Brands Inc. intends to use the net proceeds of the offering for general corporate purposes and possible future acquisitions and growth opportunities.

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering. Digital Offering, LLC is acting as financial advisor for the offering.

This offering is being made pursuant to a registration statement on Form S-1 (No. 333- 256344), as amended, previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and subsequently declared effective on June 17, 2021. A preliminary prospectus describing the terms of the proposed offering has been filed with the SEC and is available on the SEC’s website located at http://www.sec.gov. A final prospectus related to the proposed offering will be filed and made available on the SEC’s website. Electronic copies of the final prospectus may be obtained, when available, from ThinkEquity, a division of Fordham Financial Management, Inc., 17 State Street, 22nd Floor, New York, New York 10004, Telephone: (877) 436-3673, Email: prospectus@think-equity.com.

The press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About FAT (Fresh. Authentic. Tasty.) Brands
FAT Brands Inc. (NASDAQ: FAT, FATBP, FATBW) (the Company) is a leading global franchising company that strategically acquires, markets and develops fast casual and casual dining restaurant concepts around the world. The Company currently owns nine restaurant brands: Fatburger, Johnny Rockets, Buffalo’s Cafe, Buffalo’s Express, Hurricane Grill & Wings, Elevation Burger, Yalla Mediterranean and Ponderosa and Bonanza Steakhouses, and franchises approximately 700 units worldwide. For more information, please visit www.fatbrands.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to significant business, economic and competitive risks, uncertainties and contingencies including, but not limited to, uncertainties surrounding the severity, duration and effects of the COVID-19 pandemic, many of which are difficult to predict and beyond our control, which could cause our actual results to differ materially from the results expressed or implied in such forward-looking statements. We refer you to the documents we file from time to time with the Securities and Exchange Commission, such as our reports on Form 10-K, Form 10-Q and Form 8-K, for a discussion of these and other risks, uncertainties and contingencies. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

Investor Relations:
ICR
Lynne Collier
IR-FATBrands@icrinc.com
646-430-2216

Media Relations:
JConnelly
Erin Mandzik
emandzik@jconnelly.com
862-246-9911

Source: FAT Brands Inc.

Release – PDS Biotechnology Corporation Announces Closing of Approximately $52 Million Public Offering

Posted on by Admin


PDS Biotechnology Corporation Announces Closing of Approximately $52 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

 

FLORHAM PARK, N.J., June 17, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotechnology” or the “Company”), a clinical-stage immunotherapy company developing a pipeline of novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced the closing of its previously announced underwritten public offering of 6,088,235 shares of common stock (inclusive of the 794,117 shares that were sold pursuant to the underwriter’s full exercise of its option to purchase additional shares of common stock) at a public offering price of $8.50 per share. Certain insiders, including certain members of the Company’s board of directors and executive officers, purchased shares of PDS Biotech common stock in the offering.

The gross proceeds to PDS Biotech from this offering, before deducting underwriting discounts, commissions and other offering expenses were approximately $51.7 million.

Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering.

The shares of common stock described above were offered by the Company pursuant to a registration statement on Form S-3 (File No. 333-240011) previously filed with the U.S. Securities and Exchange Commission (“SEC”) on July 22, 2020 and declared effective on July 31, 2020, and the accompanying prospectus contained therein. The offering of the shares of common stock was made by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement related to the offering has been filed with the SEC and is available on the SEC’s website, located at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained by contacting Cantor Fitzgerald & Co., 499 Park Avenue, 4th Floor, New York, NY 10022, Attn: Capital Markets Department, or by email at prospectus@cantor.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About PDS Biotechnology

PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline of novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology platform. Our Versamune®-based products overcome the limitations of current immunotherapy by inducing in vivo, large quantities of high-quality, highly potent polyfunctional tumor specific CD4+ helper and CD8+ killer T-cells. PDS Biotech has developed multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize diseased cells and effectively attack and destroy them. Our immuno-oncology product candidates are initially being studied in combination therapy to potentially enhance efficacy without compounding toxicity across a range of cancer types. The company’s lead investigational cancer immunotherapy product PDS0101 is currently in Phase 2 clinical studies in HPV-associated cancers. The company’s pipeline products address various cancers including breast, colon, lung, prostate and ovarian cancers. To learn more, please visit www.pdsbiotech.com or follow us on Twitter at @PDSBiotech.

About PDS0101

PDS Biotech’s lead candidate, PDS0101, combines the utility of the Versamune® platform with targeted antigens in HPV-expressing cancers.  In partnership with Merck & Co., PDS Biotech is evaluating a combination of PDS0101 and KEYTRUDA® in a Phase 2 study in first-line treatment of recurrent or metastatic head and neck cancer. PDS Biotech is also conducting two additional Phase 2 studies in advanced HPV-associated cancers and advanced localized cervical cancer with the National Cancer Institute (NCI) and The University of Texas MD Anderson Cancer Center, respectively.

About PDS0102

PDS0102 combines the utility of the Versamune® platform with the proprietary T-cell receptor gamma alternate reading frame protein (TARP), a tumor antigen identified by the National Cancer Institute (NCI) which is strongly associated with prostate cancer, breast cancer and AML. The product is in late-stage clinical development and anticipated to enter human clinical trials in 2022.

About PDS0103

PDS0103 combines the utility of the Versamune® platform with novel and proprietary highly immunogenic agonist epitopes of mucin-1 (MUC1) oncogenic C-terminal region. MUC1 is highly expressed in multiple tumor types and has been shown to be associated with drug resistance and poor disease prognosis. The product is in late-stage clinical development as part of a collaborative research and development agreement with the National Cancer Institute and anticipated to enter human clinical trials in 2022.

Forward Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the “Company”) and other matters. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the Company’s management, as well as assumptions made by, and information currently available to, management. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” “forecast,” “guidance”, “outlook” and other similar expressions among others. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the Company’s ability to protect its intellectual property rights; the Company’s anticipated capital requirements, including the Company’s anticipated cash runway and the Company’s current expectations regarding its plans for future equity financings; the Company’s dependence on additional financing to fund its operations and complete the development and commercialization of its product candidates, and the risks that raising such additional capital may restrict the Company’s operations or require the Company to relinquish rights to the Company’s technologies or product candidates; the Company’s limited operating history in the Company’s current line of business, which makes it difficult to evaluate the Company’s prospects, the Company’s business plan or the likelihood of the Company’s successful implementation of such business plan; the timing for the Company or its partners to initiate the planned clinical trials for PDS0101, PDS0203 and other Versamune® based products; the future success of such trials; the successful implementation of the Company’s research and development programs and collaborations, including any collaboration studies concerning PDS0101, PDS0203 and other Versamune® based products and the Company’s interpretation of the results and findings of such programs and collaborations and whether such results are sufficient to support the future success of the Company’s product candidates; the success, timing and cost of the Company’s ongoing clinical trials and anticipated clinical trials for the Company’s current product candidates, including statements regarding the timing of initiation, pace of enrollment and completion of the trials (including our ability to fully fund our disclosed clinical trials, which assumes no material changes to our currently projected expenses), futility analyses, presentations at conferences and data reported in an abstract, and receipt of interim results, which are not necessarily indicative of the final results of the Company’s ongoing clinical trials; any Company statements about its understanding of product candidates mechanisms of action and interpretation of preclinical and early clinical results from its clinical development programs and any collaboration studies; the acceptance by the market of the Company’s product candidates, if approved; the timing of and the Company’s ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect to, the Company’s product candidates; and other factors, including legislative, regulatory, political and economic developments not within the Company’s control, including unforeseen circumstances or other disruptions to normal business operations arising from or related to COVID-19. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk factors included in the Company’s annual and periodic reports filed with the SEC. The forward-looking statements are made only as of the date of this press release and, except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Media & Investor Relations Contact:

Deanne Randolph
PDS Biotech
Phone: +1 (908) 517-3613
Email: drandolph@pdsbiotech.com

Rich Cockrell
CG Capital
Phone: +1 (404) 736-3838
Email: rich@cg.capital

Definition of Small Cap in Relative Terms

Posted on by Admin 

Image Credit: Kirt Edblom (Flickr)


How Covid and 2020 Investors Monkeyed with the Russell Reconstitution

 

The annual Russell reconstitution redefines what the maximum capitalization amount is for a company to be listed as a small-cap stock and the minimum to be considered large-cap.  At least within their indices. The more common Investopedia definition reads: “Small-cap stocks generally have a market cap of $300 million to $2 billion and have been known to outperform their large-cap peers.” Without getting into whether the definition of “small” changes if the average is larger, or if “small” is a constant, the year-over-year change within the Russell is drastic and says a lot about the historic market event, we all experienced beginning in 2020.

 

The Covid Effect on the Russell

In 2021, the dividing line between the Russell large-cap and small-cap size breakouts rose well above any previous high. The crossover from small to large had been $2 billion in 2020 (in line with textbook definitions) one year later (today); it has more than doubled to $5.2 billion. If we flashback to just a dozen years ago, the increase was over four times the dividing line in 2009.

 

 

Recovery on Steroids

The obvious impetus for the growth of so many sectors is the strong US equity market after the fiscal and monetary stimulus. After the onset of the pandemic shook investors in March of 2020, the follow-up was for the Russell 1000 Index, the Russell 2000 Index, and the Russell Microcap Index to be lifted and deliver well above average returns for the year ending May 28, 2021 (Russell year). As shown in the graph below, the Russell 1000 rose 42.7%, and the Russell 2000 surged 64.6% for the 12-month period. The Russell Microcap index blasted even higher, clocking a return of 82.7%.

 

 

One data point of returns doesn’t tell the whole story. The way this played out, the Russell 2000 posted higher returns than the Russell 1000 for the 12-month period ending May 2021, Although the Russell 2000 fared worse than the Russell 1000 during the March 2020 downturn, and showed continued underperformance until the fourth quarter of 2020 when small-caps rallied to end the year challenging large-caps for the “win.” The Russell Microcap stocks have been on a tear since early 2021, reinforced by the January Reddit trading phenomenon.

 

Increase in Equity Issuance Impact

At close inspection, the preliminary list of additions to the Russell 3000 Index and Russell Microcap Index also uncovers increased equity issuance, this is another reason behind the record high large/small dividing line. For the 2021 reconstitution, the current list includes adding five IPOs to the Russell 1000, 38 IPOs to the Russell 2000, and 11 IPOs to the Russell Microcap Index. De-SPACs are also among the new names added to the indexes in 2021.

A year-over-year comparison of additions and deletions shows how the trend shifted from bifurcated markets to inclusive rapidly growing markets. On a net basis (additions minus deletions), the Russell 3000 will add 466 companies, compared to net deletions of 56 companies in 2020.

 

Take-Away

No other event during the year provides investors the opportunity to review a third-party breakdown of what occurred during the previous 12 months. Looking at the Russell Index Reconstitution after the historical pandemic year can help us understand where people run for safety, where they find value, and where the division between big and small is. It also helps us appreciate micro-caps, and that when it comes to investing, value matters, not size.

The newly reconstituted Russell indexes will be in effect after the market closes on June 25.

 

Suggested Reading:

Can the Market Continue to Defy Gravity?

Is Zero-Trust Architecture Enough?



Trading Accounts for Children

Do Analysts Price Targets Matter?

 

Sources:

https://www.ftserussell.com/resources/russell-reconstitution

 

Stay up to date. Follow us:

           


Stay up to date. Follow us: